 |
|
Study evaluates factors associated with racial disparities in colon cancer screening
June 24, 2008Blacks and Hispanics appear less likely to undergo colorectal cancer screening than whites because of socioeconomic, health care access and language barriers, according to a report in the June 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. However, other factors may contribute to screening disparities experienced by Asians.
Colorectal cancer screening rates lag behind those for other cancer screening tests, according to background information in the article. In addition, marked disparities appear to exist between non-Hispanic whites and racial and ethnic minorities in the United States. "Such disparities in screening may contribute to the higher colorectal cancer incidence and mortality [death] rates observed in racial/ethnic minorities relative to non-Hispanic whites," the authors write.
Anthony F. Jerant, M.D., and colleagues at the University of California Davis School of Medicine, Sacramento, analyzed data from two national surveys conducted between 2000 and 2005. A total of 22,973 adults age 50 and older answered questions about demographics, colorectal cancer screening behaviors and other social and health care factors.
Overall, 54.1 percent of the participants were screened for colorectal cancer using either colonoscopy or fecal occult blood testing (FOBT). Individuals in racial and ethnic minority groups were less likely than whites to be tested-33.8 percent of Asians, 48.2 percent of blacks and 36.7 percent of Hispanics underwent a screening procedure, compared with 57.2 percent of whites.
After adjusting for other factors associated with screening behavior-including demographics, socioeconomic variables, language spoken at home, health care access and self-rated health-disparities between blacks, Hispanics and whites disappeared, the authors note. "Beyond socioeconomic factors, which disproportionately affect minorities, these findings suggest the effect of access and, for Hispanics, language-appropriate care on colorectal cancer screening uptake," they write.
However, after adjusting for the same factors, disparities between whites and Asians remained significant. "Although this study does not permit firm conclusions regarding the reason for this finding, the implication is that unmeasured cultural factors may contribute to the Asian/non-Hispanic white disparity in colorectal cancer screening," the authors write. "Less acculturated Asian individuals in the United States may have core health beliefs and values that differ from those in the 'Western' health model, leading them to decline FOBT or endoscopy offered in the absence of worrisome symptoms. They may also be less likely to be offered colorectal cancer screening."
The findings suggest that different types of programs may improve screening rates in separate minority groups, the authors conclude. Culturally targeted interventions for patients and physicians may help address Asian individuals, enhancing access to health care may help mitigate disparities between white and black patients and maximizing access and offering language-appropriate care and information may increase the number of Hispanics who are screened.
JAMA and Archives Journals
Overall, 54.1 percent of the participants were screened for colorectal cancer using either colonoscopy or fecal occult blood testing (FOBT). Individuals in racial and ethnic minority groups were less likely than whites to be tested-33.8 percent of Asians, 48.2 percent of blacks and 36.7 percent of Hispanics underwent a screening procedure, compared with 57.2 percent of whites.
After adjusting for other factors associated with screening behavior-including demographics, socioeconomic variables, language spoken at home, health care access and self-rated health-disparities between blacks, Hispanics and whites disappeared, the authors note. "Beyond socioeconomic factors, which disproportionately affect minorities, these findings suggest the effect of access and, for Hispanics, language-appropriate care on colorectal cancer screening uptake," they write.
However, after adjusting for the same factors, disparities between whites and Asians remained significant. "Although this study does not permit firm conclusions regarding the reason for this finding, the implication is that unmeasured cultural factors may contribute to the Asian/non-Hispanic white disparity in colorectal cancer screening," the authors write. "Less acculturated Asian individuals in the United States may have core health beliefs and values that differ from those in the 'Western' health model, leading them to decline FOBT or endoscopy offered in the absence of worrisome symptoms. They may also be less likely to be offered colorectal cancer screening."
The findings suggest that different types of programs may improve screening rates in separate minority groups, the authors conclude. Culturally targeted interventions for patients and physicians may help address Asian individuals, enhancing access to health care may help mitigate disparities between white and black patients and maximizing access and offering language-appropriate care and information may increase the number of Hispanics who are screened.
JAMA and Archives Journals
Colorectal Cancer News and Current Colorectal Cancer Events RSSObesity raises risks of serious digestive health concerns
The prevalence of obesity and overweight in the United States coupled by the increased risk of gastrointestinal diseases related to obesity raises serious implications for the health of Americans.
Bowel cancer indicator should lead to better treatment
STEM cell scientists have developed a more accurate way of identifying aggressive forms of bowel cancer, which should eventually lead to better treatment and survival rates.
Stem cell indicator for bowel cancer should lead to better survival rates
Stem cell scientists have developed a more accurate way of identifying aggressive forms of bowel cancer, which should eventually lead to better treatment and survival rates. Bowel cancer is the third most common cancer in the UK.
Scientists discover major genetic cause of colorectal cancer
About one-third of colorectal cancers are inherited, but the genetic cause of most of these cancers is unknown. The genes linked to colorectal cancer account for less than 5 percent of all cases.
Perceived discrimination affects screening rates
Minority men and women who perceived discrimination from their health care providers were less likely to be screened for colorectal or breast cancer, according to a report in the August issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research.
First worldwide analysis of cancer survival finds wide variation between countries
Cancer survival varies widely between countries according to a worldwide study published online today in Lancet Oncology.* More than 100 investigators contributed to the study.
'Smothered' genes combine with mutations to yield poor outcome in cancer patients
Johns Hopkins Kimmel Cancer Center researchers have identified a set of genes in breast and colon cancers with a deadly combination of traditional mutations and "smothered" gene activity that may result in poor outcomes for patients.
Protein thought to promote cancer instead functions as a tumor suppressor, researchers report
A protein previously thought to promote colorectal cancer instead suppresses the growth of human cancer cells in culture, researchers at UT Southwestern Medical Center have found.
Different type of colon cancer vaccine reduces disease spread, Jefferson scientists show
Taking advantage of the fact that the intestines have a separate immune system from the rest of the body, scientists at the Kimmel Cancer Center at Jefferson in Philadelphia have found a way to immunize mice against the development of metastatic disease.
Certain anticancer agents could be harmful to patients with heart disease
A set of promising new anticancer agents could have unforeseen risks in individuals with heart disease, suggests research at Washington University School of Medicine in St. Louis.
More Colorectal Cancer News Articles
 | Mayo Clinic on Digestive Health, Second Edition |
 | American Cancer Society's Complete Guide to Colorectal Caner by American Cancer Society Don't die of embarrassment--get informed about colorectal cancer Although colorectal cancer is the third most common cancer found in men and women, you may be unaware of your risk and don't know what you can do to prevent this serious disease. You may be too embarrassed to ask your doctor about changes in your bowel habits or get screened for colorectal cancer. American Cancer Society's Complete... |
 | Positive Options for Colorectal Cancer: Self-Help and Treatment by Carol Ann Larson Colorectal cancer develops slowly over a period of several years, undetected, usually as polyps. It is a preventable and treatable disease if caught in time, yet most know little about how to read its symptoms. Written for the layperson, this book covers all the uncomfortable questions and answers about the disease, from prevention and warning signs, to screening and diagnosis techniques, to... |
 | What Your Doctor May Not Tell You About Colorectal Cancer: New Tests, New Treatments, New Hope by Mark Bennett Pochapin The latest edition in the bestselling What Your Doctor May Not Tell You series explodes the myths and misconceptions about the third most common-and second most deadly-form of cancer in the United States. Over 50,000 men and women die from colorectal cancer each year-a particularly alarming statistic since it is also one of the most preventable and treatable cancers. In fact, it is estimated that... |
 | Be a Survivor: Colorectal Cancer Treatment Guide (Be a Survivor) by Vladimir Lange Dr. Lange's comprehensive overview of cancer and treatment options offers detailed information using simple, concise language and a wide variety of color photos and drawings. Colorectal cancer patients need to know more about their disease, yet there is an overload of information. Be a Survivor gives the patient the specific, reliable and necessary information to make good decisions about their... |
 | Advances in Peritoneal Surface Oncology (Recent Results in Cancer Research) Malignant peritoneal disease in its various forms is a devastating condition for patients who suffer from it and it poses a significant challenge for the clinicians taking care of them. Research efforts in this field have traditionally been scarce under the assumption of a uniformly fatal and hopeless outcome. In the last few decades a renewed interest in peritoneal carcinomatosis and primary... |
 | Tumor Budding In Colorectal Cancer: Recent Progress In Colorectal Cancer Research (Horizons in Cancer Research) by Tadahiko Masaki |
 | 100 Questions & Answers About Colorectal Cancer by David Bub, Susannah Rose, Douglas Wong This book is a patient-oriented guide to dealing with colorectal cancer. A question and answer format is used to cover many topics related to this... |
 | Challenges in Colorectal Cancer The latest guidance on challenging and controversial aspects of colorectal cancerColorectal cancer is one of the most common forms of cancer in the US and Europe. Thousands of people are diagnosed with the disease every year and nearly half of these die as a result. As colorectal cancer is curable when detected early, a significant proportion of these deaths could be prevented by earlier... |
 | Molecular Genetics & Colorectal Neoplasia: A Primer for the Clinician (Developments in Oncology) by James M. Church, Graham Casey Molecular Genetics of Colorectal Neoplasia A Primer for the Clinician provides the latest information on the genetics of colorectal cancer within a context of basic genetics, describing the subject in understandable language and making it clinically relevant. In this way, clinicians can become familiar with genetic terms and techniques related to colorectal neoplasia, providing a background upon... |
| © 2008 BrightSurf.com |